N-(4-Bromophenyl)-2-methoxy-2-methylpropanamide, 95%, 1g

2,3-Difluorophenylisothiocyanate, 97.0%, 5g

[(2,3-dimethoxyphenyl)methyl](2-methylpropyl)amine, 95.0%, 10g

Fmoc-N-Me-Ala-OH, >98%, 25g

2,3-Dihydrazinylquinoxaline, 98%, 1g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2,3-dimethylbutanoic acid, 95.0%, 250mg

Silver foil 99.9% 1.0 x 100 x 100 mm 1 pc

N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxytetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-3H-purin-2-yl)isobutyramide, 97%, 100mg

(3S,4S)-4-Methoxy-1-methylpyrrolidin-3-ol, 98%, 250mg

4-Bromo-2-methoxy-1-(trifluoromethoxy)benzene, 98%, 5g

(S)-1-O-Tolylethanamine hydrochloride, 95.0%, 100mg

6-Bromobenzo[b]thiophene 1,1-dioxide, 98%, 250mg

N-(((9H-fluoren-9-yl)methoxy)carbonyl)-S-(2,3-bis(palmitoyloxy)propyl)-L-cysteine, 97%, 2g